Table 4. Comparison of purified clonal... | American Society of Hematology

Table 4.

Comparison of purified clonal CD5⁺/CD19⁺ versus fluorescence in situ hybridization (FISH) anomalies in eight patients with stable disease.*

Patient	Genetic Anomaly†	CD5⁺/CD19⁺, %*	Abnormal FISH Nuclei, %	Delta‡
* CD5⁺/CD19⁺ cells were sorted by magnetic bead methods, and their purity was confirmed by flow cytometry.
†Two anomalies are indicated by a “/” meaning that 1 clone has both genetic defects.
‡Delta is difference between percentage of purified clonal CLL B cells and numbers of FISH abnormal cells.
1	11q/13q	98	70/92	28/6
2	13q	99	92	7
3	13q	97	89	8
4	13q	96	83	13
5	+12/17p	98	59/71	39/27
6	+12	99	65	34
7	13q	95	40	55
8	13q	96	23	73

Patient	Genetic Anomaly†	CD5⁺/CD19⁺, %*	Abnormal FISH Nuclei, %	Delta‡
* CD5⁺/CD19⁺ cells were sorted by magnetic bead methods, and their purity was confirmed by flow cytometry.
†Two anomalies are indicated by a “/” meaning that 1 clone has both genetic defects.
‡Delta is difference between percentage of purified clonal CLL B cells and numbers of FISH abnormal cells.
1	11q/13q	98	70/92	28/6
2	13q	99	92	7
3	13q	97	89	8
4	13q	96	83	13
5	+12/17p	98	59/71	39/27
6	+12	99	65	34
7	13q	95	40	55
8	13q	96	23	73